Description

Microbiota I-Center (MagIC) harnesses and translates the human microbiome into cutting-edge innovations for early disease detection and prevention. We focus on advancing science in the gut microbiome and promoting entrepreneurship.

MagIC is committed to developing novel classes of microbiome diagnostics and live biotherapeutics for common diseases including obesity, cancer, autism, inflammatory disorders, and COVID-19, that will not only transform the lives of patients and their families but also accelerate Hong Kong into a world-class microbiome biotechnology hub.